Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.
about
Glycosyltransferases and non-alcoholic fatty liver diseaseMolecular Pathogenesis of NASHConjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expressionHepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjectsThe role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in miceNonalcoholic fatty liver disease: Diagnostic biomarkers.Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis modelThe definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning.Differential gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenic development.Extraintestinal manifestations of Helicobacter pylori: a concise review.Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver diseaseRole of cytokines in the pathogenesis of non-alcoholic Fatty liver disease.Insulin resistance and chronic liver disease.Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis.ER Stress and Lipid Metabolism in Adipocytes.Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.KBH-1, an herbal composition, improves hepatic steatosis and leptin resistance in high-fat diet-induced obese ratsFocus on therapeutic strategies of nonalcoholic Fatty liver diseaseRaised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control.Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model.What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population.Lipoic Acid prevents the changes of intracellular lipid partitioning by free Fatty AcidLycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury.Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice.Plasma gamma-glutamyltransferase is strongly determined by acylation stimulating protein levels independent of insulin resistance in patients with acute coronary syndrome.Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis.Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial.Recent advances in the herbal treatment of non-alcoholic Fatty liver disease.Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial.Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment.The association between Helicobacter pylori infection and insulin resistance: a systematic review.Molecular inflammation as an underlying mechanism of the aging process and age-related diseases.Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms.Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease.Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review.Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice.
P2860
Q26764913-B24319BC-617E-4E1B-8621-98514DF647B5Q28071265-A439051D-FA7F-4A5F-AEDA-8C0611C45B89Q28250778-5B4CD1C7-29C6-4858-AFBA-55FBA83E171DQ28595534-3C832754-9E24-464A-913F-BC5F44E90D9DQ30613139-48B8EDFA-9175-481D-8BDD-3007A208FC3DQ33706254-3CA88210-F64D-45D3-BA12-C6D54FAD243EQ33851125-BE7204EE-1F8F-4666-8A0D-598F958B172BQ33939269-FA612F87-202D-4792-A68E-D840F450B5E3Q34029401-035432D1-C781-4644-894B-8DC8D7A665F8Q34168418-22326AAB-1DB6-4FBE-AF1D-81D76977775AQ34401755-331EA07F-F256-46A5-B0AC-F8E194FD3190Q34971028-6C2CA5C8-62E6-4044-8638-B76E0B527AD8Q35022435-5E4C5617-7CBD-429A-87B2-304252278291Q35073012-DC411694-C088-4D2D-AB33-11E7E9A25C57Q35173451-B77B5F10-3020-4140-941D-9665C293EDF1Q35183888-EFE1D869-A8B0-4295-B246-0CC52E289DA0Q35676997-B834C70E-89FE-401C-AAFD-23CD6DE08003Q35779442-5045AC54-D827-4843-901B-0DAC6DDC4DA1Q35788887-EB38FE57-32A7-4C4F-960F-0EC7FB172E5DQ36130252-8BAE5D88-2D66-477F-86D3-EF914011F88BQ36413703-833CFEC0-FA42-42CE-9F3F-6A14821054C4Q36436401-22C523F4-D63D-49C3-87AC-52DD60FB0925Q36546630-86F2ACE2-F167-47A2-88BF-5EA48DE2F3D3Q36616784-5234254A-84AE-4C5C-B7CD-37C4830767B1Q36664453-3E29FCDE-D87C-4B4A-8974-B3514DE8FCFBQ36715146-90C25FCE-F368-4DCD-BB14-4723869EC815Q37061460-4D633F50-BC96-4DBB-A3E8-84CFEC4257E9Q37101805-AEA6B7D3-124F-4B3E-8084-75F36964E65CQ37176656-C6DE0A79-9BBB-4EBB-B81A-0E7F7FE73DB9Q37413325-BC67902F-359D-4C59-A2EC-4BF98A2A2B99Q37436340-91E79D5F-F36B-4823-9EE5-19400682B873Q37585296-E90BC37E-FCB4-49A2-91C7-E0ADC48E0CD8Q37661610-126D79B3-1C8A-4142-A15A-E675355C8681Q37847587-2F4EA488-3D02-41E0-AD96-65899C2BB3A2Q37857353-E7D0627C-E84F-43AA-9626-391DAE993B50Q37859163-E0741765-4FE0-4561-83B3-67186A8D7D70Q38137369-D2AAA240-F21B-4207-AD1C-56D6BE5E6041Q38389889-3B55BE68-0F15-4C99-B231-7ACD023C1F88Q38644618-3211658B-3B46-4B32-A54E-9741791CC5CAQ38687860-2272076F-67A6-4336-85FB-A54C9CA9AECC
P2860
Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@en
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@nl
type
label
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@en
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@nl
prefLabel
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@en
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@nl
P2093
P1476
Nonalcoholic fatty liver disea ...... resistance and adipocytokines.
@en
P2093
Christos Zavos
Jannis Kountouras
Stergios A Polyzos
P304
P356
10.2174/156652409787847191
P577
2009-04-01T00:00:00Z